Health Condition 1: C00-D49- Neoplasms
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Indian Council of Medical Research
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients with advanced cancer 2) Expected survival of less than 1 year 3) Planned for palliative chemotherapy/systemic therapy
Exclusion criteria
Exclusion criteria: 1) Patients already on palliative IV chemotherapy/ immunotherapy for more than one month 2) Patients unable to provide informed consent or complete study procedures including questionnaire 3) Patients with Eastern Cooperative Oncology Group performance status (ECOG PS) 3 4) Terminally ill patients who are planned only for best supportive care 5) Patients less than 18 years 6) Patients planned for only oral therapy 7) Patients with hematological malignancies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time toxicity indexTimepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation of Tt with QoL, financial toxicity and survival and develop a metric for incremental time toxicityTimepoint: 3 months for all parameters except survival which will be updated at 6 months, 9 months and 12 months | — |
Countries
India
Contacts
Public ContactDr Sharada Mailankody
Kasturba Medical College, Manipal
Outcome results
None listed